Financial results - LORYDIAB MED S.R.L.

Financial Summary - Lorydiab Med S.r.l.
Unique identification code: 38987996
Registration number: J28/204/2018
Nace: 8622
Sales - Ron
58.927
Net Profit - Ron
27.051
Employees
1
Open Account
Company Lorydiab Med S.r.l. with Fiscal Code 38987996 recorded a turnover of 2024 of 58.927, with a net profit of 27.051 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Lorydiab Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 9.942 24.537 35.065 40.869 47.135 58.833 58.927
Total Income - EUR - - - 9.942 24.537 35.065 40.869 47.135 58.833 58.927
Total Expenses - EUR - - - 10.201 6.256 6.602 13.898 11.300 23.409 30.256
Gross Profit/Loss - EUR - - - -259 18.281 28.463 26.971 35.835 35.423 28.672
Net Profit/Loss - EUR - - - -557 17.545 27.489 25.892 34.740 34.987 27.051
Employees - - - 0 0 0 0 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 0.7%, from 58.833 euro in the year 2023, to 58.927 euro in 2024. The Net Profit decreased by -7.740 euro, from 34.987 euro in 2023, to 27.051 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Lorydiab Med S.r.l.

Rating financiar

Financial Rating -
LORYDIAB MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Lorydiab Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Lorydiab Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Lorydiab Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Lorydiab Med S.r.l. - CUI 38987996

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 0 0 0 0 0 0 724
Current Assets - - - 567 17.290 43.950 58.420 39.469 42.382 29.711
Inventories - - - 0 324 283 440 0 0 0
Receivables - - - 161 2.456 2.964 4.572 5.786 21.282 10.202
Cash - - - 406 14.510 40.703 53.407 33.682 21.101 19.508
Shareholders Funds - - - -514 17.041 27.926 48.954 37.207 41.757 28.368
Social Capital - - - 43 42 41 40 41 40 40
Debts - - - 1.081 249 16.023 9.467 2.262 626 2.067
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 29.711 euro in 2024 which includes Inventories of 0 euro, Receivables of 10.202 euro and cash availability of 19.508 euro.
The company's Equity was valued at 28.368 euro, while total Liabilities amounted to 2.067 euro. Equity decreased by -13.155 euro, from 41.757 euro in 2023, to 28.368 in 2024.

Risk Reports Prices

Reviews - Lorydiab Med S.r.l.

Comments - Lorydiab Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.